Reuters: Health
Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema.
Sanofi and Regeneron's Dupixent shows more encouraging results
Sanofi and Regeneron's Dupixent shows more encouraging results
Reuters: Health
Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema.
Reuters: Health
Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment